Return to Home Incidence > Table

Incidence Rates Table

Data Options
Comparison Options

Incidence Rate Report by State

Prostate (Late Stage^), 2018-2022

All Races (includes Hispanic), Male, All Ages

Sorted by Rate

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 26.0 (25.9, 26.1) N/A 52,748 21.9
Puerto Rico 2 16.0 (15.3, 16.8) N/A 369 11.3
Alabama 2 18.8 (18.1, 19.5) 51 (48, 51) 604 16.6
Nevada 2 19.1 (18.3, 20.1) 50 (47, 51) 372 19.4
Arizona 2 19.3 (18.7, 19.9) 49 (47, 51) 912 23.9
New Mexico 7 20.2 (19.1, 21.3) 48 (45, 51) 288 22.3
Wyoming 2 21.6 (19.5, 23.9) 47 (35, 51) 86 18.9
Arkansas 2 21.8 (20.8, 22.8) 46 (42, 48) 411 18.3
West Virginia 2 22.0 (20.8, 23.2) 45 (39, 48) 282 19.9
Oklahoma 2 22.0 (21.1, 22.9) 44 (41, 48) 519 20.3
Florida 2 22.5 (22.2, 22.9) 43 (41, 46) 3,559 21.0
Kansas 2 23.8 (22.7, 24.8) 42 (33, 45) 426 18.8
Alaska 2 23.8 (21.5, 26.3) 41 (21, 48) 92 20.6
Texas 7 23.8 (23.5, 24.2) 40 (35, 43) 3,527 21.4
Tennessee 2 23.9 (23.2, 24.6) 39 (34, 43) 1,034 20.3
Kentucky 7 24.0 (23.2, 24.9) 38 (33, 43) 658 19.7
Virginia 2 24.1 (23.4, 24.7) 37 (34, 43) 1,231 21.1
South Carolina 2 24.2 (23.4, 25.0) 36 (33, 42) 815 20.6
Delaware 2 24.4 (22.8, 26.2) 35 (23, 46) 169 17.3
New Jersey 7 25.1 (24.5, 25.7) 34 (30, 38) 1,435 17.1
Missouri 2 25.6 (24.9, 26.4) 33 (24, 36) 1,016 25.0
Maryland 2 25.8 (25.0, 26.6) 32 (23, 36) 946 17.7
Rhode Island 2 26.0 (24.3, 27.8) 31 (15, 41) 187 21.6
Utah 7 26.1 (24.9, 27.3) 30 (18, 37) 380 19.8
Michigan 2 26.1 (25.6, 26.7) 29 (22, 34) 1,753 21.5
Indiana 2 26.3 (25.6, 27.0) 28 (21, 34) 1,076 23.3
Georgia 7 26.3 (25.7, 27.0) 26 (21, 33) 1,543 18.2
Pennsylvania 2 26.4 (25.9, 26.9) 27 (21, 33) 2,330 23.2
California 7 26.5 (26.2, 26.8) 25 (21, 31) 5,853 25.4
North Carolina 2 26.8 (26.3, 27.4) 24 (19, 31) 1,690 19.6
Ohio 2 26.9 (26.3, 27.4) 23 (19, 31) 2,052 21.9
Maine 2 27.4 (25.9, 28.9) 22 (11, 34) 289 24.3
Mississippi 2 27.5 (26.4, 28.6) 21 (12, 31) 494 19.5
Colorado 2 27.6 (26.7, 28.4) 20 (14, 28) 888 25.9
Hawaii 7 27.8 (26.4, 29.3) 19 (9, 32) 282 26.6
Oregon 2 27.9 (27.0, 28.8) 18 (13, 26) 783 26.7
New York 7 28.1 (27.7, 28.6) 17 (14, 22) 3,478 20.4
Massachusetts 2 28.7 (27.9, 29.4) 16 (10, 21) 1,268 24.8
Nebraska 2 28.8 (27.4, 30.2) 15 (6, 24) 351 24.6
Idaho 7 28.9 (27.4, 30.4) 14 (6, 25) 326 23.5
Illinois 7 29.5 (28.9, 30.0) 13 (7, 16) 2,275 23.8
Washington 1 29.6 (28.9, 30.3) 12 (6, 16) 1,345 26.9
Connecticut 7 29.8 (28.8, 30.9) 11 (5, 17) 704 21.3
New Hampshire 2 29.9 (28.4, 31.6) 10 (4, 21) 297 24.2
Montana 2 30.0 (28.3, 31.8) 9 (4, 21) 240 22.3
Iowa 7 30.5 (29.4, 31.6) 8 (4, 15) 632 23.3
Louisiana 7 30.5 (29.6, 31.5) 7 (4, 14) 862 20.7
South Dakota 2 30.6 (28.5, 32.8) 6 (3, 21) 173 22.3
North Dakota 2 31.7 (29.4, 34.2) 5 (1, 17) 147 24.8
Wisconsin 2 32.5 (31.7, 33.3) 4 (2, 6) 1,271 24.7
Minnesota 2 34.2 (33.3, 35.1) 3 (1, 4) 1,223 27.8
District of Columbia 2 34.2 (31.3, 37.4) 2 (1, 11) 104 25.0
Vermont 2 35.0 (32.5, 37.6) 1 (1, 6) 166 29.5

Notes:
Created by statecancerprofiles.cancer.gov on 03/24/2026 7:59 am.

State Cancer Registries may provide more current or more local data.

Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.


† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

2 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

7 Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.

Return to Top